| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2140418 | Lung Cancer | 2016 | 5 Pages |
Abstract
The novel antibody 1A4 used as a prescreening method may help to reduce the false-negative rearranged ALK status if FISH or reverse transcription polymerase chain reaction results were used for validation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Qiushi Wang, Lianhua Zhao, Xin Yang, Shirong Wei, Ying Zeng, Chengyi Mao, Li Lin, Ping Fu, Liang Lyu, Zengpeng Li, Hualiang Xiao,